Kisunla (donanemab-azbt)

Kisunla (donanemab-azbt) is a prescription medicine for the treatment of Alzheimer’s disease.

Kisunla (donanemab-azbt) is currently only approved by the FDA in the USA.

  • Disease Indications : Alzheimer's disease
  • Usage : Intravenous
Medicine approved by
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)